Preview | Issue Date | Title | Author(s) | Access |
![Epigenetic and sex differences in opioid use disorder in chronic.pdf.jpg](/jspui/retrieve/1feefe51-464c-466d-91b0-38702c302af8/Epigenetic%20and%20sex%20differences%20in%20opioid%20use%20disorder%20in%20chronic.pdf.jpg) | 4-Jun-2024 | Epigenetic and sex differences in opioid use disorder in chronic pain: A real-world study linked with OPRM1 DNA methylation | Agulló, Laura; Escorial, Mónica; Orutño, Samantha; Muriel, Javier; Sandoval, Juan; Margarit, César; Peiró, Ana | ![](/image/openAccess.png) |
![Global Pain State Questionnaire Reliability, Validity, and Gender.pdf.jpg](/jspui/retrieve/3dff73a8-cab5-4e28-b389-23d1f92fdf1b/Global%20Pain%20State%20Questionnaire%20Reliability%2c%20Validity%2c%20and%20Gender.pdf.jpg) | May-2021 | Global Pain State Questionnaire: Reliability, Validity, and Gender Gap | Barrachina, Jordi; Muriel, Javier; Margarit, César; Planelles, Beatriz; Ballester, Purificación; Miguel, Richart-Martínez; Cutillas, Esperanza; Zandonai, Thomas; Peiró, Ana | ![](/image/openAccess.png) |
![Impact of CYP2D6 genotype on opioid use disorder deprescription an observational prospective study in chronic pain with sex-differences.pdf.jpg](/jspui/retrieve/ff607586-26c5-4511-a50c-c94782d71227/Impact%20of%20CYP2D6%20genotype%20on%20opioid%20use%20disorder%20deprescription%20an%20observational%20prospective%20study%20in%20chronic%20pain%20with%20sex-differences.pdf.jpg) | 2023 | Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences | Muriel, Javier; Barrachina, Jordi; Del Barco, Guillermo; Carvajal, Cristian; Escorial, Mónica; Margarit, César; Ballester, Purificación; Peiró, Ana María | ![](/image/openAccess.png) |
![Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg](/jspui/retrieve/442d251d-8781-4a09-b495-e3bbda10e4df/Long-term%20deprescription%20in%20chronic%20pain%20and%20opioid%20use%20disorder%20patients.%20Pharmacogenetic%20and%20sex%20differences.pdf.jpg) | 18-Nov-2022 | Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences | Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Non-pharmacological therapy in chronic musculoskeletal pain.pdf.jpg](/jspui/retrieve/06729c35-a4bc-4468-8fd6-f10e673682c3/Non-pharmacological%20therapy%20in%20chronic%20musculoskeletal%20pain.pdf.jpg) | Sep-2022 | Non-pharmacological therapy in chronic musculoskeletal pain | Inda, María del Mar; Margarit, César; Vara, Amaya; Cutillas, Esperanza; Mateu, Marga; Martínez, Evan; Coves, Miriam; Rodríguez, Jorge; Ballester, Purificación; Barrachina, Jordi; Morales, Domingo; Peiró, Ana | ![](/image/closedAccess.png) |
![OPRM1 influence on and effectiveness of an individualized.pdf.jpg](/jspui/retrieve/f0912f0d-190d-4252-9401-6e74eb01cbdc/OPRM1%20influence%20on%20and%20effectiveness%20of%20an%20individualized.pdf.jpg) | 2018 | OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Planelles, Beatriz; Serralta, María J.; Puga, Carmen; Inda, María del Mar; Cutillas, Esperanza; Morales, Domingo; Horga, José F. | ![](/image/closedAccess.png) |
![OPRM1 influence on and effectiveness of an individualized.pdf.jpg](/jspui/retrieve/2da87291-5d23-4d1f-88b1-3db1c6061462/OPRM1%20influence%20on%20and%20effectiveness%20of%20an%20individualized.pdf.jpg) | Aug-2018 | OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Planelles, Beatriz; Serralta, María J.; Puga, Carmen; Inda, María del Mar; Cutillas, Esperanza; Morales, Domingo; Horga, José Francisco; Peiró, Ana | ![](/image/openAccess.png) |
![Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpg](/jspui/retrieve/49e3f51c-59c2-43d1-9d15-6d348e3d5cf2/Oxycodonenaloxone%20-%20naloxone%20versus%20tapentadol%20in%20real-world%20chronic%20non-cancer%20pain%20management.an%20observational%20and%20pharmacogenetic%20study.pdf.jpg) | Jun-2022 | Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Personality and psychiatric disorders in chronic pain male affected.pdf.jpg](/jspui/retrieve/7cce012c-d596-46f4-97fd-a125c9de19e0/Personality%20and%20psychiatric%20disorders%20in%20chronic%20pain%20male%20affected.pdf.jpg) | May-2020 | Personality and psychiatric disorders in chronic pain male affected by erectile dysfunction: prospective and observational study | Ajo Ferrer, Raquel; Inda, Maria del Mar; Mateu, Margarita; Segura, Ana; Ballester, Purificación; Muriel, Javier; Sellers, Rafael; Ferrández, Guillermina; Margarit, César; Peiró, Ana | ![](/image/closedAccess.png) |
![Pharmacogenetic Guided Opioid Therapy Improves Chronic.pdf.jpg](/jspui/retrieve/1772878b-270e-4cd7-bc03-a7cb5fee6471/Pharmacogenetic%20Guided%20Opioid%20Therapy%20Improves%20Chronic.pdf.jpg) | 2023 | Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study | Agulló, Laura; Aguado, Isidro; Muriel, Javier; Margarit, César; Gómez, Alba; Escorial, Mónica; Sánchez, Astrid; Fernández, Alicia; Peiró, Ana | ![](/image/openAccess.png) |
![Pharmacogenetics and prediction of adverse events in.pdf.jpg](/jspui/retrieve/57275c95-8b6e-4e03-a7db-9b305d1d5d13/Pharmacogenetics%20and%20prediction%20of%20adverse%20events%20in.pdf.jpg) | 2018 | Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients | Muriel, Javier; Margarit, César; Barrachina, Jordi; Ballester, Purificación; Flor, Andrea; Morales, Domingo; Horga, José F.; Fernández, Eduardo; Peiró, Ana | ![](/image/closedAccess.png) |
![Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation-Genotypes Changes in Patients with Chronic Pain.pdf.jpg](/jspui/retrieve/ea9a64a5-72c7-4efd-b163-0458923f5c5e/Sex%20Differences%20in%20Opioid%20Response%20Linked%20to%20OPRM1%20and%20COMT%20genes%20DNA%20Methylation-Genotypes%20Changes%20in%20Patients%20with%20Chronic%20Pain.pdf.jpg) | 13-May-2023 | Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain | Agulló, Laura; Muriel, Javier; Margarit, César; Escorial, Mónica; Garcia, Diana; Herrero, María José; Hervás, David; Sandoval, Juan; Peiró, Ana | ![](/image/openAccess.png) |
![Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting. An observational study.pdf.jpg](/jspui/retrieve/ca542327-61b5-4184-a433-b8037a6f0828/Therapeutic%20alliance%20impact%20on%20analgesic%20outcomes%20in%20a%20real-world%20clinical%20setting.%20An%20observational%20study.pdf.jpg) | 20-Mar-2022 | Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study | Barrachina, Jordi; Margarit, César; Andreu, Blanca; Zandonai, Thomas; Ballester, Purificación; Muriel, Javier; Cutillas, Esperanza; Peiró, Ana | ![](/image/openAccess.png) |
![Use of CYP2D6 substrates and inhibitors during pain management with.pdf.jpg](/jspui/retrieve/39c55ccd-30ac-4e83-820d-84383f96018a/Use%20of%20CYP2D6%20substrates%20and%20inhibitors%20during%20pain%20management%20with.pdf.jpg) | 14-Jun-2024 | Use of CYP2D6 substrates and inhibitors during pain management with analgesic opioids: Drug-drug interactions that lead to lack of analgesic effectiveness | Muriel, J; Escorial, Mónica; Carratalá, C; Margarit, César; Barrachina, Jordi; López, A; Kringen, Marianne K; Peiró, Ana | ![](/image/openAccess.png) |